The importance of factoring in payer perspectives and reimbursement dynamics within an indication has become more critical than ever. An effective market asset strategy throughout the product lifecycle is improved by understanding the needs of payers and pharmacy benefit managers during pipeline development.
In our upcoming webinar, Evaluate Vantage's editor, Lisa Urquhart will speak to Evaluate's Sean Crowley and MMIT's Ritupriya Yamujala, Director of Solution Engineering to examine what manufacturers of successful asset launches have done differently, and how to positively impact the likelihood of a successful launch of a drug.
Join us for insights on:
- Incorporating payer views into your competitive strategy and market intelligence
- How to prioritise indications to yield the most positive responses from payers
- Future industry trends and changing market dynamics
